Valuation: Mega Lifesciences

Market Cap 2.9TCr 86Cr 77Cr 72Cr 65Cr 122.54Cr 8.33TCr 123.73Cr 860.64Cr 336.62Cr 4.23TCr 323.08Cr 316.06Cr 14TCr P/E 2026 *
12.7x
P/E 2027 * 11.7x
Enterprise Value 2.44TCr 72Cr 65Cr 60Cr 55Cr 103.02Cr 7.01TCr 104.02Cr 723.58Cr 283.01Cr 3.56TCr 271.63Cr 265.73Cr 11TCr EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.57x
Free-Float
38.66%
Yield 2026 *
5.36%
Yield 2027 * 5.74%
1 day-0.75%
1 week-1.48%
Current month-1.48%
1 month-6.99%
3 months-11.92%
6 months-0.75%
Current year-0.75%
1 week 33
Extreme 33
34
1 month 33
Extreme 33
36.75
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.25
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-1.48% - - 87Cr
-2.23%+0.87%+37.14%+102.85% 1,06000Cr
-0.66%-0.77%+35.31%+61.89% 62TCr
+0.23%+4.59%+17.57%+82.33% 48TCr
-0.33%-1.14%+64.55%+36.05% 35TCr
-2.03%+1.06%+21.08%+40.60% 35TCr
-1.92%-0.29%+10.54%+33.58% 27TCr
-2.36%-1.16%-7.14%+9.54% 25TCr
-1.56%-0.19%+37.97%+49.70% 22TCr
+0.22%-0.26%+24.41%+95.99% 18TCr
Average -1.12%-0.48%+26.83%+56.95% 42.09TCr
Weighted average by Cap. -1.28%+0.04%+30.05%+67.02%

Financials

2026 *2027 *
Net sales 1.43TCr 43Cr 38Cr 35Cr 32Cr 61Cr 4.12TCr 61Cr 425.44Cr 166.4Cr 2.09TCr 159.71Cr 156.24Cr 6.73TCr 1.55TCr 46Cr 41Cr 38Cr 35Cr 66Cr 4.46TCr 66Cr 460.13Cr 179.97Cr 2.26TCr 172.73Cr 168.98Cr 7.28TCr
Net income 224.3Cr 6.66Cr 5.95Cr 5.55Cr 5.04Cr 9.48Cr 644.82Cr 9.57Cr 67Cr 26Cr 327.66Cr 25Cr 24Cr 1.05TCr 248.59Cr 7.38Cr 6.59Cr 6.15Cr 5.58Cr 11Cr 714.64Cr 11Cr 74Cr 29Cr 363.14Cr 28Cr 27Cr 1.17TCr
Net Debt -461.67Cr -14Cr -12Cr -11Cr -10Cr -20Cr -1.33TCr -20Cr -137.06Cr -54Cr -674.42Cr -51Cr -50Cr -2.17TCr -471.98Cr -14Cr -13Cr -12Cr -11Cr -20Cr -1.36TCr -20Cr -140.12Cr -55Cr -689.46Cr -53Cr -51Cr -2.22TCr
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
08/26/08 THB 33.25 -0.75% 4,58,100
07/26/07 THB 33.50 0.00% 1,91,600
06/26/06 THB 33.50 0.00% 8,42,800
05/26/05 THB 33.50 -0.74% 2,76,700
02/26/02 THB 33.75 -0.74% 1,55,600
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
33.25THB
Average target price
42.71THB
Spread / Average Target
+28.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences